116 related articles for article (PubMed ID: 8435337)
21. Ph1-positive, bcr-negative acute leukemias: clustering of breakpoints on chromosome 22 in the 3' end of the BCR gene first intron.
Chen SJ; Chen Z; Hillion J; Grausz D; Loiseau P; Flandrin G; Berger R
Blood; 1989 Apr; 73(5):1312-5. PubMed ID: 2930840
[TBL] [Abstract][Full Text] [Related]
22. The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia.
Jeffs AR; Benjes SM; Smith TL; Sowerby SJ; Morris CM
Hum Mol Genet; 1998 May; 7(5):767-76. PubMed ID: 9536079
[TBL] [Abstract][Full Text] [Related]
23. Dual transcription of b2a2 and b3a2 BCR-ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene.
Branford S; Hughes TP; Rudzki Z
Br J Haematol; 2002 Jun; 117(4):875-7. PubMed ID: 12060123
[TBL] [Abstract][Full Text] [Related]
24. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
Kunieda Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
[TBL] [Abstract][Full Text] [Related]
25. Localization of preferential sites of rearrangement within the BCR gene in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Denny CT; Shah NP; Ogden S; Willman C; McConnell T; Crist W; Carroll A; Witte ON
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4254-8. PubMed ID: 2567002
[TBL] [Abstract][Full Text] [Related]
26. Chromosome and bcr rearrangement in chronic myelogenous leukaemia and their correlation with clinical states and prognosis of the disease.
Tien HF; Wang CH; Chen YC; Shen MC; Wu HS; Lee FY; Chuang SM; Liu CH
Br J Haematol; 1990 Aug; 75(4):469-75. PubMed ID: 2206998
[TBL] [Abstract][Full Text] [Related]
27. DNA rearrangement and restriction fragment length polymorphism within the first BCR intron in Philadelphia-positive acute leukemia.
Nakamura Y; Miura O; Sugahara Y; Maseki N; Kaneko Y; Aoki N
Am J Hematol; 1989 Sep; 32(1):24-9. PubMed ID: 2569268
[TBL] [Abstract][Full Text] [Related]
28. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
[TBL] [Abstract][Full Text] [Related]
29. Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia.
Verschraegen CF; Talpaz M; Hirsch-Ginsberg CF; Pherwani R; Rios MB; Stass SA; Kantarjian HM
Blood; 1995 May; 85(10):2705-10. PubMed ID: 7742530
[TBL] [Abstract][Full Text] [Related]
30. Study of the BCR/ABL rearrangement in patients with two Philadelphia chromosomes.
González FA; Villegas A; Asenjo S; Alvarez A; Ferro MT; Resino M
Cancer Genet Cytogenet; 1993 Oct; 70(2):153-4. PubMed ID: 8242601
[No Abstract] [Full Text] [Related]
31. Cytogenetic response to alpha-interferon is predicted in early chronic phase chronic myeloid leukemia by M-bcr breakpoint location.
Elliott SL; Taylor KM; Taylor DL; Rodwell RL; Williams BF; Shuttlewood MM; Wright SJ; Eliadis PE; Bunce IH; Frost TJ
Leukemia; 1995 Jun; 9(6):946-50. PubMed ID: 7596182
[TBL] [Abstract][Full Text] [Related]
32. Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangements.
De Melo VA; Milojkovic D; Marin D; Apperley JF; Nacheva EP; Reid AG
Cancer Genet Cytogenet; 2008 Apr; 182(2):111-5. PubMed ID: 18406872
[TBL] [Abstract][Full Text] [Related]
33. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
[TBL] [Abstract][Full Text] [Related]
34. A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p.
Pini M; Gottardi E; Scaravaglio P; Giugliano E; Libener R; Baraldi A; Muzio A; Cornaglia E; Saglio G; Levis A
Hematol J; 2002; 3(6):315-6. PubMed ID: 12522455
[No Abstract] [Full Text] [Related]
35. bcr gene rearrangement analysis in myeloproliferative disorders other than chronic myelogenous leukemia.
Crisan D; Mattson JC; O'Malley BA; Schulz RW; Wilner F
Cancer Detect Prev; 1996; 20(4):263-9. PubMed ID: 8818385
[TBL] [Abstract][Full Text] [Related]
36. Ph1+bcr- acute leukemias: implication of Alu sequences in a chromosomal translocation occurring in the new cluster region within the BCR gene.
Chen SJ; Chen Z; d'Auriol L; Le Coniat M; Grausz D; Berger R
Oncogene; 1989 Feb; 4(2):195-202. PubMed ID: 2648256
[TBL] [Abstract][Full Text] [Related]
37. Philadelphia chromosome positive B-cell type malignant lymphoma expressing an aberrant 190 kDa bcr-abl protein.
Mitani K; Sato Y; Tojo A; Ishikawa F; Kobayashi Y; Miura Y; Miyazono K; Urabe A; Takaku F
Br J Haematol; 1990 Oct; 76(2):221-5. PubMed ID: 2094324
[TBL] [Abstract][Full Text] [Related]
38. Molecular biology of the Philadelphia positive leukaemias.
Morgan GJ; Wiedemann LM
Recenti Prog Med; 1989 Oct; 80(10):508-19. PubMed ID: 2690217
[TBL] [Abstract][Full Text] [Related]
39. [Minimal residual disease in chronic myeloid disease. A practical focus].
Casado LF; Steegmann JL
Sangre (Barc); 1997 Apr; 42 Suppl 1():13-6. PubMed ID: 9381293
[No Abstract] [Full Text] [Related]
40. Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemia.
Melo JV; Hochhaus A; Yan XH; Goldman JM
Br J Haematol; 1996 Mar; 92(3):684-6. PubMed ID: 8616036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
